When and How to Take Infliximab

General considerations for when and how to take the medication include the following:
  • Infliximab is administered intravenously (by IV). Depending on the condition being treated, the drug is usually administered more frequently at the beginning of the treatment, followed by doses every six to eight weeks.
  • It will take at least two hours to administer each dose of infliximab by IV. These intravenous infusions are usually given at your healthcare provider's office or an infusion center designed for people who need regular IV medications.
  • When used for rheumatoid arthritis, infliximab is intended to be taken with methotrexate, another medication that can be taken either by mouth or by injection.
  • For the medication to work properly, it must be taken as prescribed. Infliximab will not work if you stop taking it.

Dosing Information

The dose of infliximab that your healthcare provider recommends will vary, depending on a number of factors, including:
  • Your age and weight
  • The medical condition being treated
  • Other medical conditions you may have
  • Other medications you may currently be taking.
(Click Infliximab Dosing for more information.)

Drug Interactions With Infliximab

Infliximab can potentially interact with a few medicines (see Drug Interactions With Infliximab).

What If I Take an Overdose?

The exact effects of an overdose with infliximab are not known. This is because there have been limited cases of people taking too much infliximab. In small studies, people who took large doses of the drug did not have any problems.
(Click Remicade Overdose for more information.)
Top Foods to Fight Inflammation

Infliximab Drug Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.